Cite
APA Citation
Richardson, D., Harter, P., O'Malley, D., Gonzalez-Martin, A., Herzog, T., Rogalski, C., Burger, R., & Mirza, M. (n.d.). tP037/#453 Up-next (GOG-3049/ENGOT-OV71-NSGO-CTU): a study of upifitamab rilsodotin (UPRI), a NaPi2b -directed antibody drug conjugate (ADC) in platinum-sensitive recurrent ovarian cancer. International journal of gynecological cancer, 32, A241. http://access.bl.uk/ark:/81055/vdc_100170500953.0x00004c